Description: EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning. The company was founded in 2003 and is based in Sunnyvale, California.
Home Page: ebrsystemsinc.com
EBR Technical Analysis
480 Oakmead Parkway
Sunnyvale,
CA
94085
United States
Phone:
408 720 1906
Officers
| Name | Title |
|---|---|
| Mr. Allan R. Will | Exec. Chairman |
| Mr. John G. McCutcheon | Pres, CEO & Director |
| Mr. Frank Hettmann | Chief Financial Officer |
| Mr. Michael Hendricksen | Chief Operating Officer |
| Dr. N. Parker Willis Ph.D. | Chief Technical Officer |
| Mr. Andrew Shute | Sr. VP of Global Field Operations |
| Ms. Madhuri Bhat | Chief Regulatory Officer |
| Dr. Spencer H. Kubo M.D. | Chief Medical Officer |
| Mr. Steve Sandweg | Chief Commercial Officer |
| Mr. John H. Sellers | Sec. |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.3162 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |